Journals / Retina-Vitreus / 2020 / Cilt: 29 - Sayı: 1

The Abnormal Vitreomacular Adhesion Corresponding Serous Macula Detachment Area As A Possible Ocular Risk Factor In Central Serous Chorioretinopathy

Pages
35–41
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that the frequency of VMA was 38,7% (12 eyes), 50% (10 eyes), 20% (6 eyes) in Group 1, Group 2 and Group 3, respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate the frequency of abnormal vitreomacular adhesion (VMA) in central serous chorioretinopathy (CSCR) using spectral domain optical coherence tomography (SD-OCT).
📊
Key Findings & Data:Materials and Methods: In this observational retrospective case-study, the OCT scans of 30 patients with acute CSCR (Group 1) and 15 patients with chronic CSCR (Group 2) cases which were diagnosed based on clinical, ophthalmological and OCT fi ndings and which was followed in our hospital and 30 control subjects without retinopathy (Group 3) were retrospectively reviewed.
💡
Conclusion & Impact:It was found that the frequency of VMA was 38,7% (12 eyes), 50% (10 eyes), 20% (6 eyes) in Group 1, Group 2 and Group 3, respectively.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Purpose: To investigate the frequency of abnormal vitreomacular adhesion (VMA) in central serous chorioretinopathy (CSCR) using spectral domain optical coherence tomography (SD-OCT). Materials and Methods: In this observational retrospective case-study, the OCT scans of 30 patients with acute CSCR (Group 1) and 15 patients with chronic CSCR (Group 2) cases which were diagnosed based on clinical, ophthalmological and OCT fi ndings and which was followed in our hospital and 30 control subjects without retinopathy (Group 3) were retrospectively reviewed. The frequencies of VMA in the groups were evaluated. Results: 31 eyes of 30 patients had acute CSCR and 20 eyes of 15 patients had chronic CSCR. The control group included 30 normal eyes of 30 healthy control subjects. It was found that the frequency of VMA was 38,7% (12 eyes), 50% (10 eyes), 20% (6 eyes) in Group 1, Group 2 and Group 3, respectively. The difference among the frequency of VMAs in groups was statistically signifi cant (p<0.05, p<0.05, p<0.05, respectively). Conclusion: This pilot study suggests that there is difference between the frequencies of VMA in the patients with CSCR and control group.

🔖

Cite This Article

TURGUT, B., KOBAT, S. G., ÇATAK, O. (2020). The Abnormal Vitreomacular Adhesion Corresponding Serous Macula Detachment Area As A Possible Ocular Risk Factor In Central Serous Chorioretinopathy. Retina-Vitreus, Cilt: 29 - Sayı: 1, 35–41. https://ajindex.com/articles/298908

References (16)

  1. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina 1987;7:111–131
  2. Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, et al. Central serous chorioretinopathy: Recent fi ndings and new physiopathology hypothesis. Prog Retin Eye Res 2015;48:82- 118
  3. Wang M, Munch IC, Hasler PW, Prunte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol 2008: 86(2): 126- 45
  4. Liegl R, Ulbig MW. Central serous chorioretinopathy. Ophthalmologica 2014;232(2):65-76
  5. Nicholson B, Noble J, Forooghian F, Meyerle C (2013) Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment. Surv Ophthalmol 58(2); 103–126
  6. Abouammoh MA. Advances in the treatment of central serous chorioretinopathy. Saudi J Ophthalmol 2015;29(4):278-286
  7. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121(1):26–34
  8. Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999;19(6):508–512
  9. Montero JA, Ruiz-Moreno JM. Optical coherence tomography characterization of idiopathic central serous chorioretinopathy. Br J Ophthalmol 2005;89(5);562-564
  10. Iida T, Hagimura N, Sato T, Kishi S. Evaluation of central serous chorioretinopathy with optical coherence tomography. Am J Ophthalmol 2000; 129(1):16-20
  11. Turgut B, Ergen I (2013). Santral seroz koryoretinopatinin optik koherens tomografi k paternleri (Optical Coherence Tomographic Patterns of Central Serous Chorioretinopathy). Firat Medical Journal (Firat Tip Dergisi) 18(1): 39-43
  12. Kon Y, Iida T, Maruko I, Saito M. The optical coherence tomography-ophthalmoscope for examination of central serous chorioretinopathy with precipitates. Retina 2008;28(6):864-869
  13. Turgut B, Demir T. The new landmarks, fi ndings and signs in optical coherence tomography. New Front Ophthalmol 2016;2(3):131–6
  14. Mitarai K, Gomi F, Tano Y. Three-dimensional optical coherence tomographic fi ndings in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2006;244(11):1415–1420
  15. Fujimoto H, Gomi F, Wakabayashi T, Sawa M, Tsujikawa M, Tano Y. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography. Ophthalmology 2008;115(9):1494– 1500
  16. Kim HC, Cho WB, Chung H. Morphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography.